Table 2. Indication for CRRT application according to AKIN stage.
| Total (n = 216) |
AKIN0 (n = 26) |
AKIN1 (n = 15) |
AKIN2 (n = 26) |
AKIN3 (n = 149) |
p-value | |
|---|---|---|---|---|---|---|
| Acidosis | 110(50.9%) | 10(38.5%) | 6(40.0%) | 13(50.0%) | 81(54.4%) | 0.385 |
| Azotemia | 108(50.0%) | 14(53.8%) | 5(33.3%) | 11(42.3%) | 78(52.3%) | 0.429 |
| Oliguria | 97(44.9%) | 1(3.8%) | 0(0%) | 10(38.5%) | 86(57.7%) | <0.001 |
| Hyperkalemia | 32(17.8%) | 3(11.5%) | 1(6.7%) | 3(11.5%) | 25(16.85%) | 0.640 |
| Overload | 58(26.9%) | 10(38.5%) | 7(46.7%) | 3(11.5%) | 38(25.5%) | 0.046 |
| Hypercreatinemia | 90(41.7%) | 1(3.8%) | 1(6.7%) | 7(26.9%) | 81(54.4%) | <0.001 |
| Hyperlactatemia | 117(54.2%) | 11(42.3%) | 9(60.0%) | 17(65.4%) | 80(53.7%) | 0.390 |